Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.54 |
| ▸ | TSHR | P16473 | 4/20 | 0.43 |
| ▸ | SLC1A3 | P43003 | 3/20 | 0.42 |
| ▸ | SLC1A2 | P43004 | 3/20 | 0.42 |
| ▸ | ANPEP | P15144 | 6/20 | 0.40 |
| ▸ | RNPEP | Q9H4A4 | 2/20 | 0.40 |
| ▸ | DNPEP | Q9ULA0 | 1/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.39 |
| ▸ | LAP3 | P28838 | 5/20 | 0.37 |
| ▸ | ERAP1 | Q9NZ08 | 1/20 | 0.37 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.36 |
| ▸ | SLC1A1 | P43005 | 2/20 | 0.35 |
| ▸ | LARS1 | Q9P2J5 | 1/20 | 0.34 |
| ▸ | SCN9A | Q15858 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4762688 | 1.00 | SLC7A5 (0.54) | SLC7A5TSHRSLC1A3SLC1A2ANPEP | |
| SCHEMBL22918144 | 0.86 | SLC7A5 (0.45) | SLC7A5TSHRSLC1A3SLC1A2ANPEP | |
| SCHEMBL13030938 | 0.85 | SLC7A5 (0.48) | SLC7A5TSHRSLC1A3SLC1A2ANPEP | |
| SCHEMBL13030934 | 0.85 | SLC7A5 (0.48) | SLC7A5TSHRSLC1A3SLC1A2ANPEP | |
| SCHEMBL5520321 | 0.85 | SLC7A5 (0.65) | SLC7A5SLC1A3SLC1A2ANPEPRNPEP | |
| SCHEMBL12345872 | 0.84 | SLC7A5 (0.56) | SLC7A5TSHRSLC1A3SLC1A2ANPEP | |
| SCHEMBL13144609 | 0.84 | SLC7A5 (0.56) | SLC7A5TSHRSLC1A3SLC1A2ANPEP | |
| SCHEMBL23819230 | 0.84 | SLC7A5 (0.47) | SLC7A5TSHRSLC1A3SLC1A2ANPEP | |
| SCHEMBL20898396 | 0.84 | SLC7A5 (0.57) | SLC7A5SLC1A3SLC1A2ANPEPRNPEP | |
| SCHEMBL21341120 | 0.84 | SLC7A5 (0.47) | SLC7A5TSHRSLC1A3SLC1A2ANPEP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10836707-B2 | Mild and efficient preparation method for α-acyloxyenamide compounds and use thereof in synthesis of amide and polypeptide | GUANGZHOU NEW PEPTIDE BIOMEDICAL COMPANY LIMITED (CN) | 2020-11-17 | — | — | US | disclosed |
| US-20190210957-A1 | MILD AND EFFICIENT PREPARATION METHOD FOR A-ACYLOXYENAMIDE COMPOUNDS AND USE THEREOF IN SYNTHESIS OF AMIDE AND POLYPEPTIDE | GUANGZHOU NEW PEPTIDE BIOMEDICAL COMPANY LIMITED (CN) | 2019-07-11 | — | — | US | disclosed |
| CN-103540559-A | Biofuel production by recombinant microorganisms | UNIV CALIFORNIA | 2014-01-29 | — | — | CN | disclosed |
| US-6136580-A | POLYPEPTIDE WITH ENZYMATIC ACTIVITY; FOR DIAGNOSIS, PREVENTION AND TREATMENT OF INFLAMMATION, TUMOR METASTASIS AND TISSUE REJECTION; ANTITUMOR AGENTS | THE BURNHAM INSTITUTE (US) | 2000-10-24 | — | — | US | disclosed |
| EP-0722321-A4 | SULFOXIMINE AND SULFODIIMINE MATRIX METALLOPROTEINASE INHIBITORS | UNIV FLORIDA STATE (US) | 1998-04-15 | — | — | EP | disclosed |
| EP-0722436-A4 | MERCAPTOSULFIDE METALLOPROTEINASE INHIBITORS | UNIV FLORIDA STATE (US) | 1996-11-20 | — | — | EP | disclosed |
| EP-0722321-A1 | SULFOXIMINE AND SULFODIIMINE MATRIX METALLOPROTEINASE INHIBITORS | FLORIDA STATE UNIVERSITY (US) | 1996-07-24 | — | — | EP | disclosed |
| EP-0722436-A1 | MERCAPTOSULFIDE METALLOPROTEINASE INHIBITORS | FLORIDA STATE UNIVERSITY (US) | 1996-07-24 | — | — | EP | disclosed |
| WO-1995009833-A1 | MERCAPTOSULFIDE METALLOPROTEINASE INHIBITORS | FLORIDA STATE UNIVERSITY (US) | 1995-04-13 | — | — | WO | disclosed |
| WO-1995009620-A1 | SULFOXIMINE AND SULFODIIMINE MATRIX METALLOPROTEINASE INHIBITORS | FLORIDA STATE UNIVERSITY (US) | 1995-04-13 | — | — | WO | disclosed |
| EP-0241094-B1 | PROCESS FOR THE SEPARATION OF L-LEUCINE AND L-ISOLEUCINE | PFW (NEDERLAND) B.V. (NL) | 1990-07-25 | — | — | EP | disclosed |
| US-4731476-A | Process for the separation of L-leucine and L-isoleucine | POLAK'S FRUTAL WORKS B.V. (NL) | 1988-03-15 | — | — | US | disclosed |
| EP-0241094-A1 | Process for the separation of L-leucine and L-isoleucine | PFW (NEDERLAND) B.V. (NL) | 1987-10-14 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190210957-A1 | MILD AND EFFICIENT PREPARATION METHOD FOR A-ACYLOXYENAMIDE COMPOUNDS AND USE THEREOF IN SYNTHESIS OF AMIDE AND POLYPEPTIDE | ANPEP, DNPEP, NAAA | SLC7A5 128/4885TSHR 1587/4885SLC1A3 851/4885 |
| US-10836707-B2 | Mild and efficient preparation method for α-acyloxyenamide compounds and use thereof in synthesis of amide and polypeptide | ANPEP, DNPEP, PTMA | SLC7A5 160/4885TSHR 1653/4885SLC1A3 835/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.